Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 31, 2009


Rosetta Genomics has added two new directors to its board.

The first, David Sidransky, is a professor and director of the head and neck cancer research division at Johns Hopkins University School of Medicine. He previously served as vice chairman of the board of biotech shop ImClone and is currently chairman of the board of Alfacell and Champions Biotechnology.

The second, Kenneth Berlin, was recently named Rosetta's president and CEO.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.